Flyback photovoltaic micro-inverter with a low cost and simple digital-analog control scheme

YesThe single-stage flyback Photovoltaic (PV) micro-inverter is considered as a simple and small in size topology but requires expensive digital microcontrollers such as Field-Programmable Gate Array (FPGA) or Digital Signal Processor (DSP) to increase the system efficiency, this would increase the cost of the overall system. To solve this problem, based on a single-stage flyback structure, this paper proposed a low cost and simple analog-digital control scheme. This control scheme is implemented using a low cost ATMega microcontroller built in the Arduino Uno board and some analog operational amplifiers. First, the single-stage flyback topology is analyzed theoretically and then the design consideration is obtained. Second, a 120 W prototype was developed in the laboratory to validate the proposed control. To prove the effectiveness of this control, we compared the cost price, overall system efficiency, and THD values of the proposed results with the results obtained by the literature. So, a low system component, single power stage, cheap control scheme, and decent efficiency are achieved by the proposed system. Finally, the experimental results present that the proposed system has a maximum efficiency of 91%, with good values of the total harmonic distortion (THD) compared to the results of other authorsThis work was supported in-part by Innovate UK GCRF Energy Catalyst PiCREST project under Grant number 41358, in-part by British Academy GCRF COMPENSE project under Grant GCRFNGR3\154

Atomic X-ray Spectroscopy of Accreting Black Holes

Current astrophysical research suggests that the most persistently luminous objects in the Universe are powered by the flow of matter through accretion disks onto black holes. Accretion disk systems are observed to emit copious radiation across the electromagnetic spectrum, each energy band providing access to rather distinct regimes of physical conditions and geometric scale. X-ray emission probes the innermost regions of the accretion disk, where relativistic effects prevail. While this has been known for decades, it also has been acknowledged that inferring physical conditions in the relativistic regime from the behavior of the X-ray continuum is problematic and not satisfactorily constraining. With the discovery in the 1990s of iron X-ray lines bearing signatures of relativistic distortion came the hope that such emission would more firmly constrain models of disk accretion near black holes, as well as provide observational criteria by which to test general relativity in the strong field limit. Here we provide an introduction to this phenomenon. While the presentation is intended to be primarily tutorial in nature, we aim also to acquaint the reader with trends in current research. To achieve these ends, we present the basic applications of general relativity that pertain to X-ray spectroscopic observations of black hole accretion disk systems, focusing on the Schwarzschild and Kerr solutions to the Einstein field equations. To this we add treatments of the fundamental concepts associated with the theoretical and modeling aspects of accretion disks, as well as relevant topics from observational and theoretical X-ray spectroscopy.Comment: 63 pages, 21 figures, Einstein Centennial Review Article, Canadian Journal of Physics, in pres

Active Galactic Nuclei at the Crossroads of Astrophysics

Over the last five decades, AGN studies have produced a number of spectacular examples of synergies and multifaceted approaches in astrophysics. The field of AGN research now spans the entire spectral range and covers more than twelve orders of magnitude in the spatial and temporal domains. The next generation of astrophysical facilities will open up new possibilities for AGN studies, especially in the areas of high-resolution and high-fidelity imaging and spectroscopy of nuclear regions in the X-ray, optical, and radio bands. These studies will address in detail a number of critical issues in AGN research such as processes in the immediate vicinity of supermassive black holes, physical conditions of broad-line and narrow-line regions, formation and evolution of accretion disks and relativistic outflows, and the connection between nuclear activity and galaxy evolution.Comment: 16 pages, 5 figures; review contribution; "Exploring the Cosmic Frontier: Astrophysical Instruments for the 21st Century", ESO Astrophysical Symposia Serie

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Composição em ácidos graxos da gordura na carcaça de frangos de corte sob dietas com diferentes fontes de energia Carcass fatty acid composition of broiler fed different sources of energy

Avaliaram-se os níveis de energia metabolizável normalmente utilizados nas rações de frangos de corte, obtidos pela inclusão de óleos vegetais (soja, canola e palma) e seus efeitos sobre o perfil de ácidos graxos da pele e dos músculos da coxa e do peito, levando-se em consideração a linhagem e o sexo. Foram utilizados 2400 pintos de um dia, machos e fêmeas, das linhagens comerciais Hubbard e Avian Farms. As aves receberam ração inicial e final com níveis de energia metabolizável de 3050 e 3150kcal/kg, respectivamente, obtidos pela inclusão dos óleos vegetais, fornecedores de ácidos graxos, inclusive "ômega-3". Utilizou-se um delineamento inteiramente ao acaso em um arranjo fatorial com 16 tratamentos (4 rações × 2 sexos × 2 linhagens) com duas repetições cada. Diferenças entre médias foram testadas pela dms. Não houve efeito significativo da inclusão de óleos na ração sobre o perfil de ácidos graxos na carcaça. O mesmo ocorreu quanto ao efeito de sexo e de linhagem.<br>An experiment was carried out with the objective of evaluating the effect of metabolizable energy levels, normally utilized in ration for broilers by addition of vegetable oils (soybean, rapeseed, and palm), on the profiles of fatty acids of the skin and meat of breast and thigh according sex and lineage, based on 2,400 one-day-old chicks, males and females, from Hubbard and Avian Farms. The fowls were given initial and finisher rations with metabolizable energy levels of 3,050 and 3,150kcal/kg, respectively, obtained by the inclusion of vegetable oils, which provided fatty acids, including "omega-3". The initial and finisher control rations were based on corn and soybean, without oil inclusion, with metabolizable energy levels of 2,900 and 3,000, respectively. A completely randomized design with factorial arrangement (4 rations × 2 sexes × 2 lines) and SMD test were used. No effects of sex, lineage and oil inclusion on carcass fatty acid profiles were observed